`
`
`Filed: November 12, 2019
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`____________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`___________________
`
`HUAWEI TECHNOLOGIES CO., LTD.,
`
`PETITIONER,
`
`V.
`
`BELL NORTHERN RESEARCH, LLC,
`
`PATENT OWNER.
`
`___________________
`
`Case No. IPR2019-01186
`U.S. Patent No. 7,039,435
`___________________
`
`
`PATENT OWNER’S SUR-REPLY TO PETITIONER’S REPLY
`
`
`
`I.
`
`THE DISTRICT COURT CASE SCHEDULE
`
`Contrary to the Petitioner’s assertion, there is nothing “tentative” about the
`
`district court’s schedule for the related actions. There is a date certain set for every
`
`pre-trial deadline, including the pre-trial conference, which is confirmed—not
`
`“tentatively scheduled” (see Rep., 1)—for March 20, 2020 at 2:30 p.m. (Ex. 2001,
`
`¶29.) It strains credibility that the Court, having had the parties submit final exhibit
`
`lists, witness lists, and all other submissions for the case to be trial-ready, would
`
`then wait ten months or more to actually conduct the trial. Lest there be any doubt,
`
`the default scheduling rules in the Southern District of California for patent cases
`
`call for “[a] trial date…within twenty-four (24) months for complex cases.” (Ex.
`
`2002 (SDCA Patent Local Rules) at Patent L.R. 2.1(a).) Twenty-four months from
`
`Patent Owner’s complaint filing is August 1, 2020. (See Pet., 2.)
`
`Moreover, the remaining presently scheduled litigation deadlines are
`
`unlikely to change. Petitioner already tried—and failed—to modify the schedule.
`
`Despite the court’s warning in the scheduling order that “[t]he dates and times set
`
`forth herein will not be modified except for good cause shown” (Ex. 2001, ¶30),
`
`Petitioner filed a request to extend the case deadlines due to anticipated discovery
`
`delays resulting from Petitioner’s status on the “Entity List” for the U.S.
`
`government’s export ban. (Ex. 2003, at 9.) The court granted relief that the parties
`
`agreed upon—permission to conduct limited discovery after the fact discovery
`
`
`
`1
`
`
`
`deadline—but denied Petitioner’s request to generally extend deadlines, stating,
`
`“[a]ll of the current dates and deadlines will remain as set.” (Ex. 2004, at 2.)
`
`Petitioner misconstrues the district court’s comments on PTAB proceedings.
`
`First, as Petitioner’s first block quote shows, in June of 2019, the court shared the
`
`Board’s concern regarding parallel proceedings. (See Rep., 1 (quoting district
`
`court’s statement asking first whether any IPRs had been instituted and then stating
`
`“I’m rather loathe to go on parallel tracks with the Patent Office.”) The Board’s
`
`analogous statements in NHK in very similar circumstances are precisely why
`
`Patent Owner seeks denial of the Petition under § 314(a). (See POPR at 25-28.)
`
`While the court stated that it would “consider the efficiencies of proceeding”
`
`(Rep., 2) if an IPR is instituted, it is highly probable that the court would consider
`
`it efficient to continue to trial when some of the most significant costs of
`
`litigating—fact and expert discovery—will already have been incurred, and the
`
`case will be nearly trial ready. This situation is the opposite of “an inexpensive
`
`substitute for district court litigation.” Instead, it would derail a process that is near
`
`completion and has already expended substantial party and district court resources.
`
`The overlap and redundancy of this proceeding with the related litigation is
`
`confirmed through Petitioner’s expert technical reports served in the related
`
`litigation on October 11, 2019. Petitioner confirmed it intended to rely in the
`
`litigation on the same expert (Dr. Wells) to include the same prior art anticipation
`
`
`
`2
`
`
`
`and obviousness opinions and arguments as those identified as Grounds 1-6 in this
`
`proceeding. (Compare Petition at 5 with Ex. 2005 at 487-545). Accordingly, rather
`
`than an “inexpensive alternative” to district court litigation, this proceeding, if
`
`instituted, would duplicate the related district court litigation.
`
`Second, nowhere does NHK state that the Board should consider the district
`
`court’s views on IPRs in exercising its discretion under § 314(a). Such a holding
`
`would lead to wild inconsistencies, depending on the views of which judge
`
`happened to preside over a related litigation, rather than objective facts such as the
`
`case schedule and overlap between the two tracks—which is what NHK focuses
`
`on. See NHK Spring Co., Ltd. v. Intri-Plex Technologies, Inc., IPR2018-00752,
`
`Paper No. 8 at 19-20 (PTAB Sept. 12, 2018).
`
`Third, Petitioner attempts to cast doubt on the “near certainty” that any jury
`
`trial in the related litigation would conclude long before any Final Written
`
`Decision in these proceedings, if instituted, by pointing out that the parties reached
`
`an agreement in principle with respect to the litigation. (Rep. at 2, n.1). More
`
`importantly, Huawei agreed to move to terminate its pending inter partes reviews
`
`against Patent Owner as part of the settlement. Accordingly, in any event,
`
`institution should be denied because either (i) without a final settlement, these
`
`proceedings will duplicate the related litigation, or (ii) with a final settlement,
`
`Huawei agreed to move to terminate its pending IPRs against Patent Owner.
`
`
`
`3
`
`
`
`II. THE EXAMINER’S REVIEW OF IRVIN AND THE DATE OF THE
`REFERENCE
`
`Petitioner asserts that the Board should disregard that Irvin was considered
`
`by the Examiner. But Irvin was not “merely” cited in an IDS. (Rep. 5). As
`
`discussed in the POPR at 36-39, Irvin was individually identified in its own
`
`separate IDS, and in conjunction with the Examiner’s review and consideration of
`
`Irvin, the examiner specifically emphasized that that none of the prior art
`
`(including Irvin, which he had just reviewed) disclosed the “transmit
`
`power…based on [the] network adjusted power…and proximity transmit power
`
`level” limitation—precisely what Petitioner now argues Irvin discloses.
`
`Petitioner does not dispute the authority cited at pp. 41-43 of the POPR that
`
`written support for solely a single claim is insufficient to prove an earlier effective
`
`prior art date for a specific reference. Yet that is all Petitioner has attempted to
`
`show—that claim 1 is supported by the provisional. The only other evidence
`
`Petitioner has submitted is a conclusory expert declaration that the respective
`
`disclosures within Irvin and its provisional are “substantially similar.” Petitioner
`
`cites no authority to support their position that specifications in the Irvin
`
`provisional that are merely substantially similar—whatever that may mean—are
`
`sufficient to provide the necessary written support for everything in Irvin relied
`
`upon in the Petition. Petitioner’s unfounded claims about what Patent Owner
`
`knows or should know are irrelevant to Petitioner’s failure to meet its burden here.
`
`
`
`4
`
`
`
`III. THE EVIDENCE OF ANTEDATING
`Petitioner’s attack of the disclosures in the inventor’s conception document
`
`(Ex. 2031) are unavailing. Petitioner focuses on a single claim element, i.e.,
`
`network adjusted power level as a function of a position to a communication tower.
`
`(Rep. 4). While the inventor deposition testimony it points to suggests that the
`
`precise words of this claim element are not in this document, the inventor testified
`
`this limitation was otherwise described in the document. (Ex. 2026, 215:7-217:5).
`
`This is analogous to situations where a claim is supported by the disclosure of a
`
`specification even if the exact words are not used. See Blue Calypso, LLC v.
`
`Groupon, Inc., 815 F.3d 1331, 1345 (Fed. Cir. 2016) (“when examining the written
`
`description for support for the claimed invention . . . the exact terms appearing in
`
`the claim ‘need not be used in haec verba.’”) (citations omitted.).
`
`Petitioner calls this inquiry a “fact issue.” As an initial matter, there are a
`
`plethora of other reasons for denying institution that do not rest upon antedating.
`
`But also, critically, merely asserting something is a fact issue, without necessary
`
`evidence to create a disputed fact is insufficient to meet Petitioner’s burden. See,
`
`British Airways Bd. v. Boeing Co., 585 F.2d 946, 952 (9th Cir. 1978) (Attorney
`
`argument not evidence and cannot create a factual dispute); Invitrogen Corp. v.
`
`Clontech Labs., Inc., 429 F.3d 1052, 1068 (Fed. Cir. 2005) (unsubstantiated legal
`
`argument on technical evidence no substitute for substantiated expert testimony.)
`
`
`
`5
`
`
`
`Respectfully Submitted,
`
`/Alexander E. Gasser/
`Steven W. Hartsell (Reg. No. 58,788)
`SKIERMONT DERBY LLP
`1601 Elm St., Ste. 4400
`Dallas, Texas 75201
`P: 214-978-6600/F: 214-978-6601
`Lead Counsel for Patent Owner
`
`Alexander E. Gasser (Reg. No. 48,760)
`Sarah E. Spires (Reg. No. 61,501)
`SKIERMONT DERBY LLP
`1601 Elm St., Ste. 4400
`Dallas, Texas 75201
`P: 214-978-6600/F: 214-978-6621
`Back-Up Counsel for Patent Owner
`
`Dated: November 12, 2019
`
`
`
`
`
`
`
`
`
`
`6
`
`
`
`CERTIFICATE OF SERVICE
`
`I certify that I caused to be served on the counsel for Petitioner a true and
`
`correct copy of the foregoing Sur-Reply to Petitioner’s Preliminary Reply, by
`
`electronic means on November 12, 2019 at the following addresses of record:
`
`Respectfully Submitted,
`
`/Alexander E. Gasser/
`Alexander E. Gasser (Reg. No. 48,760)
`Back-Up Counsel for Patent Owner
`
`Michael T. Hawkins
`Craig Deutsch
`Sangki Park
`Christopher Hoff
`Jason W. Wolff
`Kim Leung
`Jennifer Huang
`IPR35548-0101IP1@fr.com
`hawkins@fr.com
`PTABInbound@fr.com
`
`Dated: November 12, 2019
`
`
`
`
`
`
`
`
`
`
`
`
`
`7
`
`